The Manila Times

Shockwave Centers of America Provides Mark V Rolling Cart for Shockwave Therapy Equipment Mobility

Shockwave Centers of America provides the Mark V Rolling Cart to support mobility of shockwave therapy systems in clinical ...
Oncology Nurse Advisor

Outpatient Monitoring of CAR T-Cell Therapy Reduces Hospitalization, With No Impact on Mortality

Outpatient monitoring of CAR T-cell therapy reduces healthcare resource utilization and hospital days without impacting 30-day mortality, finds ASCO study.
News-Medical.Net

Off-the-shelf CAR T therapy targets treatment-resistant systemic sclerosis

Today at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived ...
Hub

An inside job

Building on recent successes, scientists are focused on a promising new frontier: sending tiny particles into the body to ...
Fierce Biotech

Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease

Fate Therapeutics has seen improvements in 4 patients with treatment-resistant systemic sclerosis who were dosed with it | ...

New data highlight off-the-shelf iPSC-derived CAR T-cell therapy for treatment-resistant systemic sclerosis

New preliminary clinical data presented at ISSCR 2026 evaluated an induced pluripotent stem cell (iPSC)-derived CAR T-cell ...

Gleneagles Hospital helps brain cancer patient to recover through indigenous CAR-T cell therapy

Gleneagles Hospital Chennai successfully treated a brain cancer patient using indigenous CAR-T cell therapy, leading to full recovery.
CURE

What Patients Should Know About Preparing for Cell Therapy

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers

(formerly Wugen, Inc.), a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for ...

BBG Advanced Therapies Launches Mobile Leukapheresis Center, in Collaboration with Kite to Bring CAR T-cell Therapies Closer to Patients

BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration ...

New approach could expand CAR T therapy from blood cancers to solid tumors

Researchers at the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute report that ...
The Manila Times

Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...